Nu Holdings has seen its market value fall over 35% since January, underperforming other Brazilian banks. Despite this, it remains a high-growth bank with strong return on equity (ROE) and significant expansion opportunities. In Brazil, Nu captures only 7% of the profit pool and has low penetration in small and medium enterprises, indicating untapped potential. Its Mexican operations have reached breakeven with less than 1% market share in an underbanked, fast-growing market. Valued at a 14.7x price-to-earnings ratio for fiscal year 2026 and boasting over 30% ROE, Nu offers attractive value amid ongoing loan and earnings growth.
Nu Holdings, the parent of Nubank, is trading around $13.16, down 30% from its highs but showing strong fundamentals with over 135 million customers and its first $5 billion revenue quarter. Despite a recent market pullback due to rising credit losse...
The Latin American alternative lending market is projected to grow at a 14.4% CAGR from 2026 to 2029, reaching approximately $10 billion by 2029, up from $5.9 billion in 2025. Growth is fueled by expanding e-commerce, integration of credit into digit...
Nu Holdings reported robust growth with a 29% return on equity and an expanding loan portfolio, signaling strong profitability. Despite some short-term earnings volatility due to higher expected credit losses and a declining ROE, the company's Q1 rev...
Stocks priced under $30 often get overlooked, but Pfizer and Nu Holdings stand out with solid balance sheets and growth potential. Pfizer, a global biopharma giant, trades around $25 with a strong dividend yield and promising pipeline despite some re...
Nu Holdings is initiated with a buy rating due to its strong year-over-year customer and financial growth, including 42% revenue increase and improved efficiency. Despite some mixed quarter-over-quarter trends, the company is expanding market share a...
